Cindy Smith joins the show along with her sister Susan, and Doctor James Cleary

• Cindy is with her twin sister Susan and they are both tremendous Red Sox fans. 
• Cindy was diagnosed in May 2015. She wasn't feeling well and was having stomach issues. Initially she was misdiagnosed with having food allergies. Further tests showed spots on her liver and neuroendocrine cancer was discovered. 
• The cancer was also causing heart issues. 
• Cindy chose to come to Dana-Farber at the urging of her twin sister who pointed out that her cancer is rare and she should go to a hospital that has a lot of experience treating something rare. 
• She had undergone three chemoembolizations, which is when three chemotherapy drugs are injected into the artery that supplies blood to the tumor in the liver. 
• This past year as her cancer advanced she started a new treatment that was not available when she was first diagnosed. She says it’s a perfect example of what research can do and why going to a hospital like Dana-Farber can make all the difference. 
• Cindy was supposed to appear on the Radio-Telethon last year, but her health took a turn for the worse and she had to cancel her appearance the day before. She was truly heartbroken. 
• This year she is doing much better and Dr. Cleary said it is a high honor to be able to appear alongside her. 
• Cindy retired from her job at Bank Home Town this past year, which has been incredibly supportive of her. Bank Home Town made a $2,500 donation last year

when she was supposed to appear on Radio-Telethon and they are making a donation again this year. 

• She is also an artist with a passion for painting and she used to own an art studio. Through art she has hosted fundraisers for Dr. Cleary every year, raising more than $16,000 to date and counting! Dr. Cleary has been able to attend some of her art shows. 

Dr. James Cleary 

• Dr. Cleary is an oncologist who specializes in gastrointestinal cancers. In addition to treating patients with neuroendocrine cancer, he treats malignancies including pancreatic, colon, rectal, biliary, and liver. 
• He was awarded a Lustgarten Foundation/Stand Up To Cancer (SU2C) grant in support of his work developing new therapies for patients with pancreatic cancer. Dr. Cleary has over 30 publications in such journals as The New England Journal of Medicine, The Lancet, The Journal of Clinical Oncology, Cancer Discovery, and The Journal of Clinical Investigation. In addition to his research activities, he has won awards for both his clinical care at Dana-Farber and his teaching at Harvard Medical School.